Your session is about to expire
← Back to Search
Hyperpolarized Xe129 for Coronavirus
Study Summary
This trial will help researchers understand how different levels of COVID-19 severity affect pulmonary function and how quickly patients recover.
- Coronavirus
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What additional investigations have explored the effects of Hyperpolarized Xe129?
"There are currently 15 Hyperpolarized Xe129 trials in progress, none of which are at their final stage. The majority of these experiments take place in Philadelphia but span across 21 medical locations."
Are healthcare professionals authorized to use Hyperpolarized Xe129 in treatment?
"Due to the limited amount of research data available, Hyperpolarized Xe129 has been given a safety rating of 1. As this is a Phase 1 trial, there is minimal evidence for efficacy and safety at present."
Are there any open slots left for participants in this research?
"Verified. Information hosted on clinicaltrials.gov confirms that this research endeavour, which was originally launched on February 22nd 2021, is currently recruiting individuals for participation. 20 persons need to be recruited from 1 medical centre."
How many participants are engaged in this trial?
"Affirmative. The records on clinicaltrials.gov verify that recruitment for this medical trial is still active since it was created in February 2021 and recently updated in August 2022. Currently, the research team needs to acquire 20 participants from a single facility."
Share this study with friends
Copy Link
Messenger